← Back to Search

Focus Groups for Human Immunodeficiency Virus Infection

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 9 months
Awards & highlights

Study Summary

This trial aims to understand experiences unique to transgender men who have sex with men and how they affect HIV risk.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Transgender

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-hoc thematic analysis across five domains

Trial Design

1Treatment groups
Experimental Treatment
Group I: Focus GroupsExperimental Treatment1 Intervention
Focus groups will occur during the course of the study period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transgender men's perspectives on HIV risk and HIV prevention interventions
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,601 Previous Clinical Trials
915,626 Total Patients Enrolled
~15 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top